ReviewPhysiological reports2026
Amino acid homeostasis in the kidney: Physiological roles and pathological dysregulation.
Review in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Amino acids are fundamental to life as protein building blocks and key regulators of metabolism and signaling. The kidney plays a critical, yet underappreciated, role in amino acid homeostasis through three interconnected pillars: selective glomerular filtration, efficient tubular reabsorption, and metabolic processing, which includes de novo synthesis and interconversion of amino acids, as well as their catabolism for energy production and gluconeogenesis. These processes are tightly coupled to systemic acid-base regulation, gluconeogenesis, and whole-body nitrogen clearance. When kidney function declines, the resulting alterations in amino acid profiles are not merely passive markers of reduced filtration but are increasingly recognized as potential mediators that may actively contribute to disease progression, as supported by a growing body of preclinical and clinical evidence. This Review synthesizes current knowledge on renal amino acid homeostasis and proposes four dysregulation patterns in kidney disease: metabolic rewiring, branched-chain amino acids paradox, uremic toxin accumulation, and organelle dysfunction. We further discuss emerging therapeutic strategies aimed at restoring amino acid homeostasis, including dietary modulation, pharmacological targeting of metabolic enzymes and transporters, and microbiome-directed interventions. Finally, we identify key unanswered questions that should guide future research in this rapidly evolving field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.